From the Magnetic Resonance Unit (F.X.A., C.A., J.A., M.A., A.R.), Department of Radiology
Department of Automatic Control (F.X.A.), Universitat Politècnica de Catalunya-Barcelona Tech, Barcelona, Spain.
AJNR Am J Neuroradiol. 2018 Feb;39(2):399-404. doi: 10.3174/ajnr.A5495. Epub 2017 Dec 28.
Cervical cord atrophy has been associated with clinical disability in multiple sclerosis and is proposed as an outcome measure of neurodegeneration. The aim of this study was to quantify the development of cervical cord atrophy and to evaluate its association with disability progression in patients with primary-progressive multiple sclerosis.
Thirty-one patients with primary-progressive multiple sclerosis underwent 1.5T brain and spinal cord MR imaging at baseline and 6-7 years later. The cervical spinal cord from C1 to C5 was segmented to evaluate the normalized overall cross-sectional area and the cross-sectional area of C2-C3, C3-C4, and C4-C5. The annualized rates of normalized cross-sectional area loss were also evaluated. To estimate clinical progression, we determined the Expanded Disability Status Scale score at baseline and at 2 and 14 years after baseline to compute the normalized area under the curve of the Expanded Disability Status Scale and the Expanded Disability Status Scale changes from baseline to the follow-up time points. Associations between the cord cross-sectional area and brain MR imaging and clinical measures were also investigated. Finally, the value of all these measures for predicting long-term disability was evaluated.
Some normalized cross-sectional area measurements showed moderate correlations with the normalized area under the curve of the Expanded Disability Status Scale, ranging from -0.439 to -0.359 ( < .05). Moreover, the annualized rate of the normalized mean cross-sectional area loss and the baseline Expanded Disability Status Scale were independent predictors of long-term disability progression.
These data indicate that development of cervical cord atrophy is associated with progression of disability and is predictive of this event in patients with primary-progressive MS.
颈髓萎缩与多发性硬化症的临床残疾有关,并被提议作为神经退行性变的结果测量指标。本研究的目的是定量评估原发性进展型多发性硬化症患者颈髓萎缩的发展,并评估其与残疾进展的相关性。
31 例原发性进展型多发性硬化症患者在基线和 6-7 年后进行 1.5T 脑和脊髓 MRI 检查。对 C1 至 C5 的颈脊髓进行分段,以评估归一化总体横截面积以及 C2-C3、C3-C4 和 C4-C5 的横截面积。还评估了归一化横截面积损失的年增长率。为了估计临床进展,我们在基线和基线后 2 年和 14 年确定扩展残疾状态量表评分,以计算扩展残疾状态量表的归一化曲线下面积和扩展残疾状态量表从基线到随访时间点的变化。还研究了脊髓横截面积与脑 MRI 和临床测量之间的相关性。最后,评估了所有这些措施对预测长期残疾的价值。
一些归一化横截面积测量值与扩展残疾状态量表的归一化曲线下面积呈中度相关,范围从-0.439 到-0.359(<0.05)。此外,归一化平均横截面积损失的年增长率和基线扩展残疾状态量表是长期残疾进展的独立预测因子。
这些数据表明颈髓萎缩的发展与残疾的进展有关,并可预测原发性进展型多发性硬化症患者的这一事件。